新興病原体に対する抗生物質
Michael A Fischbach1, Christopher T Walsh
1Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114, USA. fischbach@fischbachgroup.org
まとめ
新種の抗生物質の支架を発見し,薬剤耐性菌の増加と闘うための新しい戦略が緊急に必要とされています. 新しい微生物源を探索し,合成分子を再利用することは,抗生物質開発の有望な道を示しています.
科学分野:
- 微生物学 微生物学とは
- 薬用化学 薬用化学について
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 保健施設や地域社会で抗生物質耐性病原菌の流行が増加しています.
- 新しい抗生物質の開発の進展は,確立された分子構造に依存しているため,遅くなっています.
- 多剤耐性の出現は,新しい抗生物質の支架の発見を必要とします.
研究 の 目的:
- 新しい抗生物質の支架の緊急の必要性を強調するために.
- 新しい抗生物質の支架を発見するための有望なアプローチについて議論する.
- バクテリアの病原体における多剤耐性の課題に取り組むために.
主な方法:
- 自然製品のための未調査の微生物のニッチを採掘する.
- 既知の支架の再発見を避けるようにスクリーニング方法を設計する.
- 既存の合成分子ライブラリを,抗生物質の発見のために再利用する.
主要な成果:
- 新種の抗生物質のエスカフォールドの発見のための有望なアプローチの特定.
- 多剤耐性病原菌との闘いにおける新たな抗生物質の可能性.
- 伝統的な合成裁縫を超えて戦略の多様化.
結論:
- 新しい分子構造の発見は,抗生物質耐性との闘いにおける優先事項である.
- 微生物のニッチを探索し,合成ライブラリを再利用するなどの新しいアプローチは,有望であることを示しています.
- 新しい抗生物質の緊急開発は,公衆衛生にとって極めて重要です.
関連する概念動画
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection
Overview
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...


